Sign In
Buy IBIO
$1.84
+0.0800 (+4.55%)
At Close: Jun 03, 2026
iBio earnings preview: what to expect
02:01pm, Sunday, 14'th Nov 2021 Business Insider Markets
iBio will be reporting Q1 earnings on November 15. Wall Street analysts expect iBio will be reporting losses per share of $0.050. Go here to track iBio stock price in real-time ahead of earnings. On November 15, iBio will
iBio to Report Fiscal 2022 First Quarter Financial Results and Provide Corporate Update on Monday, November 15, 2021
04:30pm, Monday, 08'th Nov 2021
BRYAN, Texas, Nov. 08, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based
Hot Penny Stocks to Watch That You Might've Missed This Week
04:49pm, Friday, 08'th Oct 2021
Looking for penny stocks to buy with high-momentum right now? Check these three out for your list The post Hot Penny Stocks to Watch That You Might've Missed This Week appeared first on Penny Stocks t
This Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream
07:31am, Saturday, 02'nd Oct 2021
Pre-clinical successes lead to exclusive licensing agreements for iBio.
iBio, Inc. (IBIO) CEO Thomas Isett on Q4 Fiscal 2021 Results - Earnings Call Transcript
11:54am, Monday, 27'th Sep 2021
iBio, Inc. (IBIO) CEO Thomas Isett on Q4 Fiscal 2021 Results - Earnings Call Transcript
iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
07:30am, Monday, 27'th Sep 2021
Expanded Immuno-Oncology Pipeline with License of Next-Gen anti-CD25 Antibody for Solid Tumors
iBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference
04:30pm, Monday, 20'th Sep 2021
BRYAN, Texas, Sept. 20, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-base
BRYAN, Texas, Sept. 20, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-base
7 Meme Stocks to Sell Before They Go to $0
08:54am, Thursday, 16'th Sep 2021
Meme stocks have enjoyed another recent surge. However, don't get caught holding the bag with these seven less promising ones.
iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference
04:30pm, Tuesday, 07'th Sep 2021
BRYAN, Texas, Sept. 07, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-base
iBio Appoints William D. Clark to its Board of Directors
07:00am, Thursday, 26'th Aug 2021
Industry veteran adds deep expertise in immuno-oncology to the Board Industry veteran adds deep expertise in immuno-oncology to the Board
iBio Expands Immuno-Oncology Pipeline With RubrYc Deal
11:16am, Wednesday, 25'th Aug 2021
iBio Inc (NYSE: IBIO) has signed an exclusive license agreement with RubrYc Therapeutics Inc for RTX-003, an immunotherapy candidate targeting regulatory T cells (Tregs). Related: IBio Adds Thr
iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics
07:30am, Wednesday, 25'th Aug 2021
– iBio licenses a novel antibody targeting regulatory T cells –
Best Biotech Penny Stocks For Your Small-Caps Watchlist Right Now
09:15am, Wednesday, 04'th Aug 2021
Biotech penny stocks are heating up right now; here's 3 to watch The post Best Biotech Penny Stocks For Your Small-Caps Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Infor
